Similar to HNSCC cells, DAC treatment up-regulated PTGS2 and PGE2 receptors’ expression in both AML cell lines, and CYP2E1 expression in SKM-1 cells (Fig. 6E, Supplementary Fig. S8A). The gene discussed is CYP2E1; the disease is head and neck squamous cell carcinoma.